Ipsen SA annual operating cash flow
2020
2021
2022
2023
2024
2025
Ipsen SA Operating Cash Flow Growth & History (IPN)
Ipsen SA's operating cash flow was €1.14B for fiscal 2025.
View full Ipsen SA company overviewIpsen SA annual operating cash flow history
| Fiscal year | Period ended | Operating cash flow | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €1.14B | €222.9M | +24.35% |
| 2024 | 2024-12-31 | €915.5M | €49.6M | +5.73% |
| 2023 | 2023-12-31 | €865.9M | −€105.5M | −10.86% |
| 2022 | 2022-12-31 | €971.4M | €78.1M | +8.74% |
| 2021 | 2021-12-31 | €893.3M | €122.0M | +15.82% |
| 2020 | 2020-12-31 | €771.3M | — | — |
Ipsen SA operating cash flow trends
Over the last five fiscal years, Ipsen SA's operating cash flow increased from €771.3M to €1.14B, a change of €367.1M.
About the metric
What operating cash flow means
Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.
Calculation and source
reported operating cash flow
TickerStat standardizes net cash provided by or used in operating activities reported in company official filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ipsen SA source filings ↗Community posts
Ipsen lifts annual growth and margin forecasts after strong drug sales
Ipsen ($IPN) raised its 2026 sales-growth target to approximately 23% at constant exchange rates, from more than 20%, and its core operating-margin forecast to around 39%, from above 37%. Third-quarter revenue reached €1.17 billion, increas ...
